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Abstract 
Background: Cerenkov Luminescence Imaging detects the light emitted when a charged particle 
travels through a medium with a velocity greater than the phase velocity of light in that medium. The 
beta-particles emitted from many radionuclides used in nuclear medicine have sufficient kinetic 
energy to satisfy the requirement.  
Purpose: This thesis aimed to examine the physical and optical properties affecting the radiance of 
Cerenkov radiation measured in the new imaging modality Cerenkov Luminescence Imaging (CLI). In 
difference to established preclinical imaging modalities detecting radionuclides such as Positron 
Emission Tomography (PET) and Single Photon Emission Computed Tomography (SPECT), CLI detects 
Cerenkov emission. This radiation is within the optical spectral range, as opposed to high energy 
photons emitted as a product of the radioactive decay. Better understanding of these properties 
could possibly enable quantitative measurements of radionuclide uptake in animal tumor models.  
Materials and method: Mouse-sized phantoms of varying scattering and absorbing properties with 
channels drilled at different depths were filled with 18F and imaged with a laboratory-built CLI-
system. Images of varying exposure times were collected repeatedly during a number of half-lives of 
18F. The radiance and FWHM were analyzed with MATLAB and the custom-made MATLAB-program 
OptiScope. For comparison to established imaging modalities, the phantoms were imaged in three 
different preclinical PET-systems, including the box-geometry system Genisys4 (Sofie BioSciences).  
Results: The radiance of the Cerenkov radiation was found to be proportional to the activity present 
in the channels of the phantoms. Increasing depth of the cannels was found to decrease the radiance 
measured, as did increasing absorption coefficient. An increasing scattering coefficient was found to 
increase the radiance over the range examined. Increasing depth and scattering coefficient showed a 
broadening of the FWHM, while an increasing absorption coefficient narrowed the FWHM. The 
FWHM measured for a variety of depths down to 1 cm and varying scattering and absorption 
coefficients, ranged between 0.4- 3.8 cm.  
Conclusion: CLI is limited by its complicated relationship between activity and radiance. Due to the 
many factors affecting the emitted light at the surface of the phantoms, the radiance could not 
directly be used as a quantitative measurement of the activity uptake. For this to be possible some 
form of normalization for the effective attenuation coefficient would be needed and the imaging 
could only be done for uptakes close to the surface of the subject. The coefficient could be assessed 
with an external light source.  
CLI will never challenge PET as an equally efficient quantitative imaging modality for preclinical 
imaging, but could become a part of an imaging scheme where a combination of modalities is used to 
utilize the benefits of each system.    
  
3  
 
Populärvetenskaplig sammanfattning 
Laddade partiklar med hög energi kan ibland färdas snabbare än ljusets hastighet i det medium det 
för stunden befinner sig i. När detta sker, emitteras så kallat Cerenkovljus. Ljuset ligger inom det 
synliga spektret och kan alltså detekteras med vanlig kamerateknik.  
Många av de radionuklider som används för nukleärmedicinska undersökningar och terapier 
emitterar högenergetiska laddade partiklar när de sönderfaller. Dessa kan få tillräckligt hög hastighet 
för att vid passage genom kroppen emittera Cerenkovljus.  
Nukleärmedicinska radionuklider används även för prekliniska metoder och tidigare studier har visat 
att Cerenkov Luminance Imaging (CLI), en metod där man studerar det emitterade Cerenkov ljuset 
från försöksdjur injicerade med radionuklider, skulle kunna användas för prekliniska studier av 
nukleärmedicinska terapier och läkemedel. 
När ljus färdas genom vävnad kommer det spridas och absorberas och endast en liten del av ljuset, 
om något, kommer ta sig upp till ytan. Om man ska kunna kvantifiera vilken mängd radioaktivitet 
som gett upphov till ljuset, måste man ta reda på hur ljuset har påverkats av sin färd mot ytan.  
I detta arbete utfördes så kallade fantommätningar för att studera hur spridning, absorption och djup 
i vävnad påverkar vilken mängd ljus man kan detektera. Fantomen bestod av mus-stora epoxiharts-
block med olika optiska egenskaper som fick dem att absorbera och sprida ljuset olika mycket. 
Genom fantomen hade kanaler borrats med varierande avstånd till ytan för att simulera 
aktivitetsupptag på olika djup i en muskropp. Försöken gjordes med en ljustät låda som stänger ute 
vanligt ljus och en så kallad CCD-kamera monterad inuti lådan som kan detektera ljuset. Fantomen 
fylldes med radionukliden 18F, en vanlig nuklid vid PET-undersökningar och placerades i CLI-lådan. 
Bilder med varierande insamlingstid togs upprepade gånger under flera timmars tid, medan 
aktivitetsinnehållet i fantomen sönderföll.  
För att jämföra CLI:s potential som nukleärmedicinsk bildverktyg utfördes 
Positronemissionstomografi (PET)-undersökningar av samma fantom med 18F i tre olika prekliniska 
PET-system, däribland det box-geometriska systemet Genisys4.  
Resultaten visade att radiansen sjönk som funktion av djupet och för stigande 
absorptionsegenskaper i fantomens material. Spridande partiklar i fantomen ökade radiansen. 
Upplösningen blev sämre för ökande djup och för stigande mängd spridande partiklar. Absorberande 
material förbättrade upplösningen något.  
Resultaten visade på de hinder som måste överbryggas för att CLI ska kunna användas som ett 
kvantitativt nukleärmedicinskt bildverktyg, eftersom ljuset som detekteras inte direkt kan översättas 
till ett radionuklidupptag i muskroppen. Först måste radiansen normeras mot en effektiv 
attenueringskoefficient som beskriver hur ljusets intensitet förändras på sin väg mot ytan. Dessutom 
kommer CLI bara kunna användas till ytligt belägna aktivitetsupptag, så som tumörer implanterade 
under huden på försöksdjur.  
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Introduction 
In recent decades preclinical imaging systems such as Single Photon Emission Computed Tomography 
(SPECT), Positron Emission Tomography (PET), Computed Tomography (CT) and Magnetic Resonance 
Imaging (MRI) have become leading techniques for monitoring biological and molecular processes 
[1]. These systems give opportunities to study molecular and metabolic transport pathways as well as 
giving insight into tissue functionality and pathology. The introduction of these modalities for small 
animal imaging has opened up new opportunities to assess new imaging markers and drugs, as well 
new techniques to study the diseases themselves. In some cases, these developments can be directly 
converted to clinical applications, while other form advances in preclinical imaging itself.    
PET is becoming an important tool for studies of cellular and molecular processes [1]. It can be used 
for quantitative studies of biological and molecular processes in vivo, through labeling compounds 
with positron emitters. PET radionuclides, such as 11C and 18F, have the advantage of forming 
radiotracer compounds which do not change the biological behavior of the tracer, compared to many 
radionuclides used for SPECT. But, they often have quite short half-lives, which puts a restraint on 
their availability and are therefore more demanding to work with [2].    
PET and the other imaging modalities differ slightly in function and abilities, but seem to have one 
crucial property in common: they are all quite expensive. The machines are costly to buy and run, 
and large studies with many experimental animals will demand ample machine time, increasing the 
cost even more. Only larger institutions will afford to invest in the necessary equipment, and 
research teams will have to wait in line to perform their studies.  
There is therefore a demand and interest to create simpler and cheaper imaging techniques, that can 
be utilized in smaller laboratories in connection to other equipment necessary when working with 
laboratory animals.    
With a simpler PET model, the Genisys4 TableTop PET (Sofia Biosciences, Culver City, CA) takes care 
of some of the extra weight put on by preclinical PET systems, by reducing the number of crystals to 
four detector panels, arranged in a box geometry. The system is smaller than most preclinical PET-
systems and fit on a desktop, preferably next to the computer workstation.  
The relatively new imaging modality Cerenkov Luminescence Imaging (CLI) has raised hope of a new 
tool for bio-imaging. It makes use of the Cerenkov radiation emitted when a charged particle with 
sufficient energy passes through a dielectric medium, e.g. a positron emitted from a PET radiotracer.  
The challenge for CLI is to quantify the light signal as a function of the activity of the radiotracer. 
Since the emitted Cerenkov light is a function of many parameters, this is more easily said than done. 
Pioneering research groups have taken the initial and vital steps to prove the possibility to use CLI for 
quantitative preclinical bio-imaging studies. But for it to truly challenge the established imaging 
modalities a sure connection between radiance and radioactivity, taking into account the effect of 
tissue absorption, scattering and depth, must be set up. Also, the systems sensitivity and spatial 
resolution must be examined and described.  
The work presented in this thesis aimed to investigate the physical and optical properties affecting 
the radiance measured in CLI measurements. Phantoms with varying scattering and absorption 
properties as well as varying depths for the positron emitting radionuclide were constructed. Using 
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this approach, the effect of the properties on radiance and spatial resolution could be studied one at 
a time. This gave an opportunity to evaluate the obstacles in need to be bridged if CLI is ever to be 
used for quantitative studies. To give a perspective of CLIs performance the same phantoms were 
imaged in three different preclinical PET-systems, including the Genisys4.        
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Basic theory 
Cerenkov radiation  
When a high speed charged particle travels through a dielectric1 medium, its associated 
electromagnetic field will polarize the medium along its path. Electrons of the atoms in the medium 
become displaced, creating the local polarization.  This is not a form of excitation and neither is the 
electron removed from its bound state, but a displacement of the electron in the medium´s lattice. 
When the electrons return to their normal positions they radiate photons. In the normal case, these 
will interfere destructively with each other and is therefore never seen. But, if the velocity of the 
charged particle is greater than the phase velocity2 of light in the dielectric medium, the emitted 
waves (wavelets) from each polarized point in the medium will interfere constructively since all the 
points are in phase. Coherent radiation is then emitted [3].    
The proof for the origin of Cerenkov radiation was originally given by Pavel Alekseyevich Cerenkov, 
who won the Nobel Prize for his discovery in 1958 together with Ilya Frank and Igor Tamm.  
For a charged particle travelling from point A to B (see Figure 1 below)  in a dielectric medium with 
the refractive index n at the velocity   , coherent Cerenkov radiation will be emitted while 
 
 
      , where c is the speed of light in vacuum. The ratio between the velocity of the particle 
and the speed of light in vacuum is often denoted    
  
 
 . The wave front lies along the line AC and 
the emitted waves travel with the velocity     
 
 
 . For a time interval    the particle will travel the 
distance              and the emitted waves will travel the distance         
 
 
  .  
This gives the Cerenkov relation, namely 
     
  
  
 
 
  
 
Equation 1 
                                                          
1
 A dielectric is an electrical insulator, meaning it can be polarized by an applied electric field. When having an external field 
applied, charges do not flow through the medium as with a conductor, but are only slightly displaced from their average 
position, causing a dielectric polarization.   
 
2 Phase velocity is the rate at which the phase of a wave propagates. This is not the same as group velocity, which is the 
velocity with which the envelope of a wave propagates. The phase velocity does not carry any energy or information, which 
is why there is no limit for particles to have a greater velocity than the phase velocity.  
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Figure 1 The charged particle traveling from point A to B with a velocity greater than the phase velocity will emit 
Cerenkov radiation along the line BC at an angle θ to the particle. 
The quantity   is related to the kinetic energy E of the particle and its rest mass m. When the 
particles velocity is close to the speed of light, its energy can be calculated trough the relativistic 
relationship 
      
[
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√    
  ]    
Equation 2 
Equation 2 can be used to calculate what kinetic energy for a charged particle of mass m equals a 
velocity which satisfies the condition    
 
 
 , where n is the refractive index of the medium through 
which the particle is traveling.  
From Equation 1 two important conditions can be observed. The equation has a threshold when 
  
 
 
 and     and there is a maximum angle   at which Cerenkov radiation can be emitted. When 
     i.e. when the particle velocity grows closer to the velocity of light in vacuum, c, the maximum 
angle is given by 
        
  
 
 
 
Equation 3 
We can also observe that as the refractive index increases, the threshold velocity for Cerenkov 
radiation from the particle decreases. A charged particle will therefore need a lower velocity to emit 
Cerenkov radiation in water than in air, since air has a lower refractive index than water.   
The Frank-Tamm equation 
As mentioned earlier Cerenkov shared his Nobel Prize with two other scientists. They gave the 
theoretical description of the Cerenkov radiations origin. The amount of Cerenkov radiation emitted 
for a given frequency can be calculated by the Frank-Tamm formula [3].  The energy dE emitted per 
path length dx traveled by the particle per angular frequency dω can be calculated as 
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Equation 4 
Here  ( ) is the frequency dependent permeability of the medium and   is the charge of the 
particle. By integrating Equation 4 over the angular frequency, the total energy radiated per unit 
length is given by 
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Equation 5 
The Frank-Tamm formula gives the relationship  
  
  
   
  
  
 
 
  
    
Equation 6 
This tells us that the emission is inversely proportional to the cube of the wavelength, an explanation 
to why the Cerenkov radiation is most intensive for shorter wavelengths and appears blue [3].   
As shown by several, the Frank-Tamm formula can be integrated for a given interval of wavelengths 
[4, 5].  The formula calculates the number of photons in a given region of wavelengths produced 
along the particles path. 
  
  
    (  
 
    
)∫
 
  
  
  
  
    
Equation 7 
This equation shows that the spectral distribution of the Cerenkov intensity is inversely proportional 
to the cube of the wavelength, leading to the peak of the photon spectrum in the visual range of light 
to be at the shorter wavelength, namely the blue.    
From Equation 5 we can see that the spectrum of the Cerenkov radiation is continuous. The upper 
limit of the spectrum (i.e. shorter wavelengths) is when n becomes less then unity, i.e. when 
Equation 1 is not satisfied. This happens when the emitted radiation gets up to about X-ray 
frequencies. The refractive index is a function of frequency (and therefore also wavelength, this is 
called dispersion), as the frequency is increased the refractive index decreases, and as it becomes 
less than unity the condition is no longer satisfied. The lower limit (for longer wavelengths) occurs 
because of self-absorption in the medium [3].  
Continuous slowing down approximation 
A charged particle travelling through a medium will collide and scatter against atomic electrons and 
nuclei through elastic and inelastic collisions. This will reduce the energy of the particle and change 
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its direction. A common definition of the range of the charged particle is calculated with the 
Continuous slowing down approximation (CSDA): 
 
      ∫ (
  
  
)    ∫ (
  
  
)
  
     
  
 
  
 
 
Equation 8 
This is the range travelled by the charged particle after losing all its initial energy E0. To find the range 
the particle travels while emitting Cerenkov radiation, the lower limit of the integral in Equation 8 
can be set to the limit energy calculated from Equation 2. 
The quota 
  
  
 is often called the stopping power and is meant to cover all forms of energy losses a 
charged particle experiences along its path, why it sometimes is given the subscript (
  
  
)
   
.  
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Optics in biological tissue 
With discussing light in optical imaging one refers to electromagnetic radiation with wavelengths 
between a few hundred up to about a thousand nanometers. It includes the visible range, which 
ranges from about 400 to 700 nm, ultraviolet radiation and also the near and far infrared region of 
the electromagnetic spectrum. In imaging the wavelengths above 650 nm are of special interest as 
this is called the water window, or the diagnostic window. It has minimal attenuation of light due to 
absorbers and has still a low level of absorption due to water [6].  
Biological tissues can be broken down into the cells, their organelles and the intra- and the 
extracellular structures. Within the complex matrix there is a constant variation of refractive indices 
between the different structures and many different absorbing chromophores.  
Radiance 
Radiance (L) is a measure of the quantity of radiation passing through a surface within a given solid 
angle. The SI unit of radiance is one watt per steradian per square meter (1 W sr-1 m-2). But, in optical 
imaging radiance is often given as the number of photons passing through a surface for a given solid 
angle per second (1 p s-1 cm-2 sr-1). This is the reason why in the literature, the relationship between 
the intensity of the emitted Cerenkov radiation and its wavelength is so often described as 1/λ2, 
instead of 1/λ3 as given by the theoretical description by Frank-Tamm in Equation 6. In both cases 
however, the peak of the intensity of the Cerenkov radiation will be at shorter wavelengths, i.e. blue 
light. Unlike fluorescence, the Cerenkov radiation spectra is continuous, without characteristic 
spectral peaks [7].    
Scattering 
Light scattering is the redirection of the path of photons [8]. Scattering of light in biological tissue is 
believed to be because of the varying refractive indices between structures in- and outside of the 
cells. It causes the reflection, refraction and diffraction of light as it travels through the tissue. The 
average distance a photon travels in biological tissue before being scattered is in the order of 0.01-
0.1 mm [6]. A light source embedded in tissue will therefore have a broader distribution at the 
surface. Also, structure size will affect the scattering within the tissue.  
In a macroscopic approach to describe scattering in tissue, two quantities are used [9].    is called 
the scattering coefficient and gives the probability for scatter per unit length. The anisotropy factor is 
given by   〈    ( )〉 and gives the average scatter direction. In an isotropic medium where the 
probability for scattering is equal in all directions g=0. In tissue g=0.9, which equals scattering in a 
forward direction [6]. g=1 is when the scatter angle is zero and all light propagates in the forward 
direction.  
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Figure 2 The anisotropy factor (g) describes the direction in which light is scattered. For an isotropic medium where the 
probability for scatter is equal in all angles g=0. As the probability approaches unity for the forward direction, the 
anisotropy factor approaches 1. Image from [6]. 
 
The reduced scattering coefficient   
  takes the anisotropy into account and is given by 
  
  (   )   
Equation 9 
The wavelength dependence of the reduced scattering coefficient can be described as  
  
       
Equation 10 
Here a is the scatter amplitude for the wavelength λ, it describes the density of spherical particles in 
the tissue, while b is the scatter power and is a measure of the size of the sphere. The scatter power 
decreases when particle size increases [9]. The reduced scattering coefficient decreases as a function 
of wavelength but can be seen as constant over the optical window [6]. Absorption is much more 
wavelength dependent. For the study of Cerenkov light propagating through tissue from a point of 
emission, as in CLI, scattering will set a limit to the spatial resolution of the system. 
Absorption 
Absorption is the transfer of the photon energy to a molecule, resulting in the loss of energy [8]. It 
leads to an attenuation of light and a reduction of the light intensity. Absorption of light may happen 
when a photon with energy equal to the energy difference between two electron states in a 
chromophore, is incident on such a chromophore and excites the electron [9]. Absorption contrast 
can be utilized as a medical application, since there is a large difference between the absorption 
spectra of oxygenized and deoxygenated hemoglobin. The radiance of light transmitted through a 
tissue can therefore give a measure of the oxygenation level of blood in that tissue [6].   
If scattering in tissue can be considered negligible, then the reduction of intensity for light traveling 
through tissue can be described by the Beer-Lambert law: 
 
  ( )    ( )   
     
Equation 11 
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In Equation 11     is the absorption coefficient and d is the distance travelled by the photon in the 
tissue. The absorption coefficient, as in analogy with the scattering coefficient, describes the 
probability of absorption per unit length. Intuitively, the probability for absorption of light at a given 
wavelength λ will be greater in tissues with high concentration of chromophores. The absorption 
coefficient can therefore be described as 
  ( )  ∑  ( )[  ]
 
 
Equation 12 
Here    is the extinction coefficient, describing the probability for absorption of a photon of a given 
wavelength for the i:th chromophore and C is the concentration of the i:th form of chromophore. In 
Figure 3 below, the absorption coefficients of water and hemoglobin is plotted as a function of 
wavelength over the optical window. It shows an increasing difference between the two as the 
wavelength is decreased, closing in on the blue light of Cerenkov radiation. Blood is an important 
chromophore, and variation of blood content in different tissues can lead to a big difference in light 
absorption. 
 
Figure 3 Absorption coefficient for water and hemoglobin as a function of wavelength. Image from [8]. 
For the study of Cerenkov light propagating through tissue from a point of emission, as in CLI, 
absorption will set a limit to the sensitivity of the system. 
Effective Attenuation coefficient 
To simplify the description of light deflection in tissue [9, 10], a combined coefficient for both 
scattering and absorption can be described as 
     √    (     
 ) 
Equation 13 
The radiance at a surface from a source emitting light a distance R below the surface is then 
proportional to 
  
        
 
      
Equation 14 
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Absorbing chromophores  
For the optical window in biological tissues, the most important absorbing chomophores are 
hemoglobin, water and lipids. Hemoglobin, the molecule transporting oxygen by the blood to all vital 
tissues in the body, can either be oxygenated or deoxygenated, giving it different absorbing 
properties.  Water mainly absorbs in the near infrared region of wavelengths. Lipids are similar to 
water in mostly absorbing at longer wavelengths. As described in Equation 12, the absorption 
coefficient can be described as the sum of the concentration times the extinction coefficient for each 
chromophore. Considering the most important chromophores,     becomes 
                               
Equation 15 
Here    ,      ,    and    are the extinction coefficients for deoxygenated hemoglobin, oxygenated 
hemoglobin, water and lipids.    ,      ,    and    are the concentrations of deoxygenated 
hemoglobin, oxygenated hemoglobin, water and lipids.   
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Cerenkov Luminescence Imaging 
As described previously, Cerenkov radiation has been long known, and observed in other areas. But it 
was only recently the idea of using it for optical imaging of radiotracers was presented.  Originally the 
emission of Cerenkov radiation from 18F, a common radiotracers used both clinically and pre-
clinically, was shown by Cho et al [11]. They used a CCD to detect light emitted from a microfluidic 
chip filled with 18F. By assessment of the light properties, they showed that Cerenkov radiation was 
the likely source of the light. 
CLI systems 
In a large part of the articles published on CLI, the studies have been done on equipment built for 
preclinical in vivo optical imaging, such as bioluminescence. An often quoted system is the Xenogen 
IVIS 100 or 200 (Caliper Life Sciences) [5, 12, 13]. 
The Charged Coupled Device 
Charged coupled device (CCD) is the most common detector used for various optical imaging 
modalities. The inventors of the CCD were honored with the Nobel Prize in Physics 2009. CCDs are 
made up as a grid of elements similar to capacitors, acting as potential wells for electrons [6]. 
Incident photons create free electrons through photoelectric effect. These electrons are then 
trapped in a well and remains there with a linear relation between the number of incident photons 
and the created number of electrons. But the linearity can be disrupted. When a well is almost full it 
can be difficult for new electrons to enter the well. The trapped electrons create a negative electric 
field which can limit new electrons from entering a well or may lead to electrons spilling over into 
neighboring wells. The wells are emptied when an external electrical field is applied. This makes all 
the electrons move simultaneously, why the information about the incident photons per 
element/well is preserved. One row or column in the grid is emptied at a time by being shifted with 
an electrical field onto an analog-to-digital converter (ADC).    
The sensitivity, or more precisely the quantum efficiency, of a CCD is in the range of 95%  in 
dedicated wavelength regions [6]. This means that a photon has a 95 % chance to add electrons to 
the pixel well. The sensitivity will be affected by read out noise, i.e. electrons added or lost from the 
signal during the amplification. Dark noise arises mostly from electrons released from thermal 
energy. Cooling the CCD lowers the dark noise, but this is only helpful when the system is used for 
long exposure times.   
Early work in CLI 
The idea of CLI was first proposed by Robertson et al. They showed that two different radiotracers 
labeled with high energy positron emitters, 18F and 13N, emit Cerenkov radiation after decay in a 
medium and can be detected with a CCD [12]. They gave proof-of-concept for using radiotracers in in 
vivo studies of the emitted Cerenkov radiation. Robertson et al, imaged well-plates prepared with 
various activities of positron emitting radionuclides, showing that the signal increased linearly with 
increased activity. They also showed that the radiance from 13N for a given activity was higher than 
from 18F. This was explained with the higher average energy of the emitted positron from 13N. A 
subsequent experiment was performed in which the activity was mixed with solutions of varying 
refractive index. The study showed that the radiance increased as the refractive index increased. This 
was explained consistent with the reduction of the speed of light, and therefore reduction of the 
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threshold energy required for the charged particle to produce Cerenkov radiation, when the 
refractive index increases.  
Shortly after Robertson et al. published the first article on CLI, Liu et al. showed that light was 
emitted from 18FDG, Na18F, Na 131I, 90YCl3 and a 
90Y labeled tumor targeting peptide, and that the 
probes could be imaged in vivo with optical imaging [14]. They also ruled out that the CCD signal of 
these probes was contributed by either β+ or β- by covering the sources with black and white paper, 
which resulted in a loss in signal, with the black paper showing a better signal blocking. Optical 
photons would be expected to be stopped by paper, while high energy β-particles could penetrate 
the barrier. They also concluded that the likelihood of the origin being Cerenkov radiation was 
strengthened by the continuity of the detected spectrum and the increased light output as the 
refractive index of the medium increased.    
Ruggiero et al. added more radionuclides to the list of possible probes for CLI. They evaluated the 
positron emitters 18F, 64Cu, 89Zr and 124I, the β-emitter 131I, and α-particle emitter 225Ac [15]. Solutions 
of decreasing activity concentration in water were imaged with optical imaging. The positron 
emitters were also imaged with PET. For all the radionuclides, a linear correlation between the 
radiance and the activity concentration were found. The radiance was plotted against time. A linear 
regression analysis between the reduction of radiance against the radioactive decay gave a good 
correlation (R=0.98), indicating that the light detected originated from the decay of the radionuclide. 
As a quantitative assessment of the images, the average radiance versus the mean activity measured 
by the PET on the positron emitting radionuclides were plotted, showing a linear relationship. It was 
taken to suggest that CLI could be used for quantitative studies. Similar experiments had previously 
been performed by others [12, 14]. 
With the help of Equation 2, the threshold energy for a charged particle passing through a medium of 
refractive index n to emit Cerenkov radiation can be calculated. For water, which has a refractive 
index of n=1.33, the particle must have a velocity of 0.75c or higher to produce Cerenkov radiation. 
From Equation 2 this gives a threshold energy for a positron of 264 keV. 225Ac is a pure α-particle 
emitter, emitting α-particles with an energy range of 5.021 to 5.830 keV, a considerably higher 
energy than the most energetic positrons studied by Ruggiero [15].  But due to the α-particles much 
larger mass, the velocity of the particles are below the threshold for Cerenkov radiation. To explain 
the light detected from 225Ac it has been suggested that it is produced by emissions form daughter 
nuclides, among which there are many β-emitters whose particles have a sufficient energy to 
produce Cerenkov radiation [16].  
Cerenkov radiation from radiotracers has opened a window for other forms of optical bio-imaging 
techniques. Most optical techniques, e.g. fluorescence imaging, are restricted to preclinical use since 
only a very few fluorescent substrates are approved for clinical use [17]. Radiotracers, on the other 
hand, are a much larger family of substrates approved for clinical use, which encourages the hope 
that CLI might have some clinical applications in the future.  
It has been stated that CLI, as a potential advantage over PET in preclinical studies, could speed up 
the process of small animal imaging. Instead of only having a single animal scanned as in a PET 
system, in a CLI system up to five animals could be simultaneously scanned, with a complementary 
white light image for anatomical reference [17].  
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Assessment measurements in previous studies 
In the pivotal article on CLI, by Robertson et al., they discussed the limitations of CLIs in vivo imaging 
applications. They stated that absorption and scattering of the Cerenkov light would lead to low light 
output and a blurring effect [12]. But in advantage to PET, they also considered the fact that 
production of Cerenkov light precedes the annihilation of the positron, making the origin of the 
Cerenkov radiation closer to the point of decay of the radionuclide.   
In their primary article on CLI, Liu et al. performed a phantom imaging study to evaluate the spatial 
resolution of 18F, 131I and 90Y. They found that for all of them, a spatial resolution of 1.2 mm could be 
achieved [14]. Robertson et al. argued in their following study on CLI in a pharmaceutical study that 
CLI analysis should include a normalization of signal by the injected dose [18]. 
Spinelli et al. did the first attempts at measuring the depth in vivo of the Cerenkov light source [4]. A 
mouse injected with 18FDG was imaged with CLI technique and showed uptake primarily in the heart 
and the bladder. Two different methods for depth calculation were examined. The first one 
depended on the wavelength dependence for tissue scattering. By assuming a point source and a 
homogenous flat slab of tissue and using a multispectral assessment of the emitted light, assuming a 
standard diffusion approximation of the light propagating through the tissue, they calculated the 
depth to the heart of the mouse to be 1 mm. With a second method they took advantage of the 
spectral distribution of the Cerenkov radiation. Using the proportion between number of photons 
and wavelength being     , the ratio of the integrated radiance of two different wavelengths can be 
calculated as  
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Equation 16 
From that the distance to the source d can be calculated as 
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Equation 17 
With the second method a depth of 1.6 mm where found. The result of the two methods was 
compared with the depth measured with MRI, found to be 1.5 mm. Boschi et al. used the two 
methods in attempt to measure the depth of a tumor in mice [19]. Only the second method could in 
this case be considered to estimate a reasonable depth of the tumor.  
In the study by Park et al. about triple modality probes (described later), Sprague-Dawley rats were 
injected in the back muscle at depth 4 and 7 mm with different activity concentrations of 124I [20]. At 
4 mm and with an integration time of 1 min, the lowest activity concentration that could be detected 
was 0.3 µCi/µL. With a scan time of 10 min the lowest activity concentration detected for the same 
depth was 0.1 µCi/µL.  At a depth of 7 mm, a 1 min scan time could detect a minimum activity 
concentration of 1 µCi/µL.  
18  
 
In vivo studies   
Robertson et al. did in their initial article on CLI a test where they detected the light emitted from a 
mouse carrying a human prostate tumor injected with 18FDG [12]. This was followed by a study with 
two mice with a colon tumor on their flank. The animals were imaged with both PET and CLI. It was 
shown from the PET that one of the tumors held a higher activity concentration. A similar 
relationship of the same proportions was noted in the CLI, implying a possibility to use CLI for activity 
assessments in preclinical studies.        
Liu at el. injected 18FDG in mice with implanted C6-Fluc glioma and imaged them with the IVIS 
Spectrum system (Caliper Life Sciences, Hopkinton, MA) for CLI and with a small animal PET system. 
18FDG could be localized and retained in the tumors with CLI. High signals were also detected in the 
bladder and brain. It was noted that the heart was hardy visualized in the CLI assessment due to its 
deep position in the mice. The organs were removed from the body of the mice and imaged again. 
High activities were mainly observed in the heart and tumor. A quantitative analysis of the images 
from both CLI and small animal PET showed good correlation of activation uptake in the organs 
between the two imaging modalities [14].   
When it had been shown by several studies that a correlation could be found between activities of a 
radionuclide measured with PET and the measured radiance from the same either phantom or 
mouse measured with CLI [12, 14, 15], Robertson et al. took the step to show how CLI could be used 
in a pharmaceutical drug study [18]. Mice inoculated subcutaneously with B-cell lymphomas where 
imaged with 18FDG both in a PET-system and in CLI, giving baseline imaging of the signal from the 
tumors. The quantitative measurements of the tumor size and uptake were done with PET. The mice 
where divided in two groups, where one group was given MLN4924, an antitumor agent known to 
efficiently shrink lymphomas. The mice of both groups were imaged several times, following the 
uptake and size of the tumors. The PET-imaging showed a reduction in tumor growth and also 
shrinkage in the treated group and continued growth in the untreated group. The measured radiance 
and radiance per injected dose showed a correlation with the development measured with the PET 
system.    
Holland et al. showed in a study the potential of using CLI “as a tool facilitating image-guided  surgical  
identification and resection of tumors based  on the optical signature of  localized radiotracers” [21]. 
They used a CLI-system to image a mouse before, during and after surgical resection of HER2/neu 
positive xenografts. The mouse had beforehand been administrated 89Zr-DFO-trastuzumab, a 
radiotracer with a known high specific uptake in the mentioned tumor. The average radiance from 
the tumor was before the surgical incision about                      .  After the mice was 
opened and the tumor was freely exposed the radiance increased to an average of     
                    , due to less attenuation and scattering in the skin that was now removed. After 
they had removed the tumor, they imaged the mouse again and showed a complete loss of signal 
from the site where the tumor recently sat. After the mouse was closed a last image was made, 
showing no optical signal. They also made a note of the fact that the absolute amount of 89Zr activity 
in the tumor post resection was only 20.4 kBq, which they considered a low concentration but 
apparently sufficient to give a guiding signal for the incision.     
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Clinical applications 
In addition to the expectation of CLI becoming an important tool in preclinical molecular imaging, 
hopes have been raised that it could also contribute in clinical applications [17]. Due to the poor 
tissue penetration of Cerenkov radiation the development has been focused on clinical applications 
where radionuclides are used to be absorbed at shallow locations in the body. An interesting area is 
treatment of thyroid gland cancer with 131I, together with other radioactive iodine isotopes also 
known as radioiodine. Its main decay mode is through β-decay, emitting negatively charged beta 
paticles, which has no simple method for detection.  
Jeong et al. made the first study that demonstrated the potential of CLI using radioiodine for both in 
vitro and in vivo application for thyroid studies [22]. They measured light emission from 131I and 124I 
assays in well-plates with many different activity concentrations and found that both radioiodine 
isotopes had a linear correlation between dose and luminometric intensity.  
Further, their study used anaplastic thyroid cancer cells and rat thyroid cells incubated with 124I 
imaged in a well-plate geometry. They found an increased light intensity with increasing number of 
cells. The light intensity showed a positive correlation with the radioactivity of the cells. For in vivo 
studies, nude mice where implanted with anaplastic thyroid cancer cells in three different positions 
with different amounts of cells. The mice were then injected with either 124I or 131I. The imaging of 
the luminescence showed clear visualization of all three implanted tumors and the luminescence 
intensity increased with increasing number of cells. But, the PET imaging with 124I carried out for 
comparison also showed uptake in the thyroid gland and in the stomach. The study also examined 
the uptake of 124I and 131I in naked mice (now without any implanted cancer or thyroid cells). The 
luminescence imaging detected emission from the neck of the mice after injection of 131I and 124I. 
Again, a correlation was found between the light emission and the measured activity from PET 
imaging of the same mice. Jeong et al. concluded that CLI can be used for radioiodine uptake in 
tumors for animal models. They discussed that for CLI to be used for in vivo thyroid study, new CLI 
techniques under development such as Cerenkov Luminescence Tomography, CLT, that in the future 
might compensate for the poor tissue penetration of Cerenkov radiation, would be needed to make 
it possible.    
Spinelli et al. showed in a recent study that they could obtain a planar image of Cerenkov radiation 
from human tissue of a patient treated with 550 MBq of 131I for hyperthyroidism [23]. They called this 
new imaging modality Cerenkography. Spinelli et al. used a cooled Electron multiplied charged 
coupled device (EMCCD), connected to a lens. The EMCCD was used in a light tight room. To avoid 
reflections from ambient light, the patents body was covered in black cloth. The EMCCD was placed 
50 cm from the patients head and neck. For anatomical reference, a photographic image was taken 
before the Cerenkov image. 
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Figure 4 The first Cerenkography image taken by Spinelli et al.[23] 
The image showed a good localization of the thyroid region. 
Thorek et al. showed the potential to use Cerenkov radiation for lymphography [24]. They showed 
how lymph nodes in rats could be localized with injection of 18F and removed by Cerenkov guided 
surgery. Dothager et al. suggested Cerenkov Radiation Energy Transfer (CRET) Imaging as a way to 
make use of the Cerenkov radiation from radioisotopes to create a stronger signal. They showed that 
Cerenkov radiation can be used to activate fluorescent nanoparticles to emit highly red-shifted light. 
This is a potential method to increase tissue penetration [7]. Kothapalli et al. demonstrated the 
possibility to use Cerenkov radiation for endoscopic imaging [25]. They used a fiber optic cable made 
for endoscopy connected to an optical imaging lens and a CCD. They showed detection of Cerenkov 
radiation both in non-invasive in vivo imaging of mice bearing C6 glioma and injected with 18F and ex 
vivo imaging of organs from such mice.  
Simulations 
To quantify the radiance from a Cerenkov light source, we need methods to calculate what 
intensities we could expect. The Cerenkov light intensity depends on the activity of the radionuclide, 
the energy distribution of its emitted charged particle (i.e. the source for the Cerenkov radiation), the 
depth of the source and the optical properties of the tissue through which it penetrates. Simulations 
have been made to estimate what radiance can be expected at the surface due to a deeply 
embedded Cerenkov source.  
A first attempt at quantifying the yield of photons from β-particle emitting radionuclides in water 
was done by Ross [26]. Ross explained that in order to determine the total photon yield from a 
Cerenkov event the Frank-Tamm equation (Equation 7) should be integrated over the particle path 
length, but this is not easily done, since the particle velocity is reduced as it propagates through the 
water making β a function of the particle energy, and the path length is in itself a function of the 
particles original energy. Also, the threshold energy for Cerenkov radiation has to be considered. 
Ross developed a calculation that integrated all these factors for the specific case of an electron in 
water up to electron energy of 4 MeV. The result presented the number of photons produced by an 
electron of a tabulated energy divided into spectral regions with a width of 50 nm from 250 nm to 
600 nm. To get the full number of photons produced one can simply add the photons of the different 
spectral regions.    
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In their calculations, Mitchell et al. began with Equation 7 and considered its different factors [5]. By 
considering the energy distribution of the emitted β-particles from the radionuclides 18F and 90Y, they 
showed that about 47 % of the emitted β-particles from 18F are above the threshold for Cerenkov 
radiation in water, while about 90 % of the β-particles from 90Y are above the threshold. With the 
help of Equation 7, the expected number of photons emitted per unit length within the wavelength 
range can be calculated as a function of β-particle energy. For a given energy, the expected number 
of photons in water can be calculated, but it does not cover the whole spectrum. And, it has to be 
taken in to account that while traveling through the water, the β-particle will lose energy and slow 
down. That leads to a lower number of photons produced per unit length, and the total number of 
photons will be lower than predicted. Mitchell et al. performed Monte Carlo simulations in which the 
β-particle emission energy spectrums from the radionuclide of interest were modeled, as well as the 
change in Cerenkov radiation intensity [5]. They also included the possibility of Cerenkov radiation 
being produced by secondary electrons. A point source was assumed at the center of a volume of 
water. They found that for 18F that the average number of photons per decay is 1.4 photons. The 
equivalent number for 90Y was 57 photons per decay. If the refractive index was raised from 1.33 
(water) to 1.4 (a refractive index similar to that of tissue) the number of photons per decay for 18F 
was 2.4 and 69 for 90Y. They compared their estimations to in vitro measurements, imaging well-
plates with known activities of 18F and 90Y in water solutions. By measuring the number of emitted 
photons per second, and from the known activity calculate the emitted number of photons per 
decay, the result can be compared to the expected number of photons from the simulations. Due to 
the geometry of the CLI system and the camera efficiency, they expected to detect less than 50 % of 
the calculated number of photons, i.e. 0.73 photons per decay for 18F and 28 for 90Y. They detected 
0.78 photons per decay for 18F and 23.7 photons per decay for 90Y, which was considered to be in 
good agreement with the estimation.        
Beattie et al. performed a similar simulation, also using the Monte Carlo method, simulating the 
expected radiance from models of phantoms they then could make a practical measurement on [13]. 
In their calculations, they took into account the effect of secondary electrons produced by γ-rays and 
annihilation photons and estimated their contribution to the total number of Cerenkov photons. 
Their models gave the opportunity to vary both the refractive index of the tissue and the photon 
cross-section, which will affect in what size secondary electrons are produced. They found a good 
match between their expected number of photons per disintegration (decay) and the measured 
radiance from the experimental comparison for a number of radionuclides. This could also be shown 
for radionuclides decaying in tissues of a varying refractive index. They also ventured to model the 
intrinsic spatial resolution for a number of radionuclides, by modeling the point spread function.  
Ackerman and Graves dug deeper into the potential of using CLI for imaging of α-emitting 
radionuclides by simulating the emitted Cerenkov radiation from a number of radionuclides [16]. It 
had been previously shown that Cerenkov radiation could be detected from the α-particle emitting 
isotope 225Ac [15], but the production of the emission had not been thoroughly studied. As for all 
charged particles, the energy necessary to produce Cerenkov light is calculated from Equation 2. 
Since the α-particle is much heavier than electrons and positrons, this threshold is much higher, and 
the energy available from α-decay is normally not enough. The α-particle has enough energy to 
ionize the medium creating free electrons, but these are not of sufficient energy to produce 
Cerenkov light. But, many of the progenies of the α-particle emitters produce γ-rays of sufficient 
energy to create electrons with kinetic energies over the Cerenkov threshold. Also, the decay chains 
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may include β-emitters producing Cerenkov light when of sufficient energy. Obviously all this makes 
the assessment of α-particle emitting radionuclides for CLI slightly more complicated than β-emitting 
ones. Ackerman and Graves showed that the Cerenkov radiation from an α-particle emitting 
radionuclide won’t be proportional to the activity until equilibrium is reached in the decay chain. For 
chains with long half-lives this factor disqualifies them from practical use in CLI. Also, if the Cerenkov 
light is not emitted from the first step in the decay chain, but produced by the emission of the 
radionuclides progeny, then the delay between the initial decay and the Cerenkov emission dissolves 
the relationship between the origin of the light and the position of the activity. Ackerman and Graves 
simulations showed that radionuclides that only decayed though α-particle emission produced few 
Cerenkov photons. The data showed that the Cerenkov radiation originated from γ-rays from nuclear 
de-excitations and Compton scattering producing electrons of sufficient energy. Ackerman and 
Graves also found that the radiance per activity concentration is a geometry dependent parameter. 
They simulated the radiance from activity concentrations of different size and shape and found that 
the same activity concentration produced different radiances.         
CLT and other adaptations of CLI 
In the field of optical imaging, Optical Tomography (OT) has been considered as a method for 
permitting quantification of light emission and a localization of its origin [8]. In OT, as with other 
tomographic modalities, the emission is studied from multiple views to determine the depth of the 
source of the emission. This way, the spatial resolution can be improved. But, the technique suffers 
from the fact that the detected light has undergone several scattering and absorption events on its 
way to the surface, strongly dependent on the tissue it traverses on its path. This diffusion can partly 
be compensated with propagation models, called the forward problem, which take into account the 
scattering and absorption properties of different tissues.   
Li et al. suggested that CLI could be used for tomographic studies, proposing the new method 
Cerenkov Luminescence Tomography (CLT) [27]. They described this technique as a way to measure 
the distribution of radioactive tracers inside a small animal, reconstructed from the surface 
measurement of Cerenkov photons using an inverse algorithm. By placing the object to be studied 
underneath a CCD and placing mirrors on each side of the object, reflecting the sides of the object 
towards the CCD, three different angles are imaged.  
Park et al. reported a basic method for creating a triple modality imaging probe for CLI/PET/MRI [20]. 
By conjugating a PET radionuclide with sufficient β-particle energy to create Cerenkov radiation in 
tissue, with a magnetic probe, imaging in all three modalities can be combined to benefit from their 
respective advantages. Park et al. combined 124I with thermally cross-linked, super paramagnetic iron 
oxide nanoparticles (TCL-SPION).   
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Positron Emission Tomography 
Positron Physics 
Positron emission is a form of nuclear decay (beta decay) where the nucleus emits a positron and a 
neutrino. The positron, being the antiparticle of the electron, only has a short lifetime, where it 
travels a short distance, the length of which depends on its kinetic energy, before it annihilates with 
an electron in the medium through which it travels. When doing so, two photons, both of 511 keV, 
are emitted at opposite direction. The angular distribution is of 0.5° FWHM at 180° [28]. For just a 
short while, before the annihilation happen, the electron and positron form a particle called 
positronium, which has a decay time of 10-10 s [29].   
To detect the annihilation events, two detectors measuring the coincidental event of two photons of 
the right energy, is the technique used in PET systems. The line between two coincidental events is 
called the line of response (LOR). The annihilation is assumed to have happened somewhere along 
the LOR.  
Radionuclides 
For use in clinical PET, there are several positron emitters that are suitable. The most commonly used 
is 18F, used frequently in the 18FDG compound. It has a half-life of 110 minutes, which is long enough 
for labelling and uptake of compounds with fairly fast accumulation. For slower compounds, such as 
monoclonal antibodies in solid tumors, more long lived radionuclides such as 124I or 89Zr are suitable 
[30]. Among the shorter lived radionuclides, 11C, 13N and 15O can be mentioned. Half-life, decay mode 
and maximum positron energy for common PET radionuclides are given in Table 1 below.  
 
Table 1 Common PET radionuclides. Data from [30]. 
Nuclide Half-life Decay mode (%) Eβ+,max [keV] 
11C 20.4 min β+ (99.8) EC (0.2) 960 
13N 9.96 min β+ (100) 1,190 
15O 2.03 min β+ (99.9) EC (0.1) 1,720 
30P 2.5 min β+ (99.8) EC (0.2) 3,250 
18F 109.6 min β+ (97) EC (3) 635 
124I 4.18 days β+ (25) EC (75) 2,140 
68Ga 68.3 min β+ (90) EC (10) 1,900 
89Zr 3.27 days β+ (33) EC (77) 902 
 
Photon interactions 
The main form of interaction for the 511 keV photons in biological tissue is Compton scattering [29]. 
The detected signal is therefore attenuated by photons being redirected away from their original 
LOR. They can still be detected as coincidences by the PET system, but may add to the number of 
scattered events (see Events below).  
Detector design 
To detect the annihilation photons, scintillator materials are the most common detectors in PET 
systems. Scintillator materials have the property of emitting light when energy is deposited by 
charged particles or high energy photons passing through them. The light emitted is proportional to 
the energy deposited, which gives the detector system a chance to discriminate against photons 
detected that has previously been scattered on their way from the annihilation point to the detector. 
To attenuate the high energy annihilation photons, the scintillator has to be dense. They should have 
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a high probability for photoelectric interactions, in which the whole energy of the photon is 
absorbed. Inevitably, Compton scatter will still be the most common interaction and thickness of the 
detector will therefore be crucial for the detector to fully stop a large fraction of the incident 
annihilation photons.  
The PET systems time resolution, which is crucial to determine which detected events are to be 
counted as coincidences, is to a large extent limited by the scintillator decay time. This is the time it 
takes for the light emitted after the energy deposit in the scintillator to be collected and later on 
transformed to an electrical signal. This is most often done by photomultiplier tubes (PMTs), 
although newer systems are utilizing semiconductor readout devices [28]. The scintillator light is 
guided to a PMT, often through a glass window and hits a photocathode, which in turn releases 
electrons. These are multiplied through the tube by hitting a number of dynodes, releasing more and 
more electrons. The current is then used as the detected signal from the PET system.  
The arrangement of the detectors is an important factor affecting the spatial resolution of the PET 
system. A common design is the block detector design, in which smaller pieces is cut into the 
scintillation block, forming an array of smaller detector crystals in a grid [28]. The space in between 
the smaller crystals is filled with a reflective medium, separating the small elements and creating a 
path for scintillation light to travel to the PMTs. Normally, the block detector is then connected to a 
small number of PMTs, avoiding the need for every small element to be coupled to its own PMT [28]. 
To increase the localization from which small crystal light is detected by the PMTs, the crystals can be 
cut with varying depths into the scintillation block. Light signals from the different small crystals then 
get a specific distribution over the PMTs, giving them a fingerprint useful to determine which crystal 
incoming scintillation light originated in [29].  
In a discrete individual design the scintillation crystals are separated by a refractive material. Each 
crystal then creates a path for the light to travel along, down to the photo detector. This is preferably 
combined with semiconductor readout devices, where each crystal is connected to an individual 
detector. This kind of detector design is more common in research and small animal PET systems 
[28].    
In a Continuous gamma camera detector, a matrix of PMT is coupled to one large scintillator block. 
Light emitted from the scintillator can be seen by several PMTs and the position of the interaction is 
decided by weighting the signal from the involved PMTs [29].    
The arrangement of the detectors can be done in a variation of ways. The most common way is in a 
ring geometry [28, 29]. If larger detectors are used, such as continuous gamma camera detectors, the 
detectors can be arranged in a polygonal geometry. For example, as a hexagonal could be made out 
of six detector panels. Cheaper systems sometimes have partial ring geometries with movable panels 
covering a fraction of the full circle. These systems allow a lower number of LOR and have to be 
rotated to detect enough data to be topographically reconstructed.  
Positron range  
Due to the fact that the positron travels a short distance between the point from which it is emitted 
to the point for the annihilation, there is a fundamental limit in the PET systems spatial resolution. 
The distance depends on the positrons kinetic energy, which for a positron from 18F has a maximum 
energy of 0.650 MeV [29]. The range also depends on the surrounding medium. The positron travels 
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longer distances in tissues of low density, such as lung tissue, than in high density tissues, such as 
bone. The scale at which the positron range affects the final resolution depends on the PET systems 
spatial resolution. 
Acollinearity  
At the annihilation, energy and mass must be conserved, for which reason the photons are emitted 
at 180°. But sometimes kinetic energy remains that reduces the angle between the photons, on 
average              [28]. As a consequence, this means that the LOR doesn’t pass through the 
annihilation point. Acolliniarity therefore reduces the spatial resolution. To what extent depends on 
the detector ring diameter, with lager diameters leading to larger errors. If a Gaussian distribution is 
assumed, the blurring effect can be estimated as: 
             
Equation 18 
Here D is the diameter of the scanner [29]. Reducing the diameter lowers the effect of acollinearity, 
but at the same time increases the DOI errors (see Spatial Resolution below). In animal PET systems, 
the diameter is quite small, why acollinearity is not a big problem [29].      
Events 
PET differs from other nuclear imaging techniques by not relying on collimation of the incident 
radiation to know its origin. Since two annihilation photons are emitted, the detection of two 
simultaneous, or as it is called, coincidental photons equals the detection of one decay event, or 
rather one annihilation event. Therefore, it is important to allow detection of photons that are not 
passing the detector perpendicular to its surface, and to have good solid angle coverage. 
The detectors of a PET system is during a regular examination hit by a large amount of photons 
detected as events, but only a smaller portion are registered as coincidences. Out of these, only an 
even smaller portion is true coincidences originating from an annihilation event. True coincidences 
are the desired detections, contributing to the detection of activity uptake [28, 29].  
Random coincidences are detected when photons from two different events are detected 
coincidentally as if originating from the same event [28, 29]. For this to happen, they need to be 
detected within the coincidence timing window (see below).  They add false information about the 
position of activity in the studied volume and therefore blur the resulting images. Random events can 
be reduced by narrowing the coincidence timing window, but that will at the same time reduce the 
PET-systems sensitivity.  
Scatter coincidences appear when either one or both of the annihilation photons from an 
annihilation event are scattered in the surrounding medium and therefore are deflected from its 
original LOR [28, 29].  They result in a loss of contrast in the resulting image. The amount of scattered 
coincidences is a function of the PET systems energy resolution, its ability to distinguish between true 
events and scattered, which through the scatter events have lost part of its energy. A PET-system 
with good energy resolution can reject more scattered photons. Still, one should remember that 
scatter events originate from real annihilation events, but will lower the spatial resolution as they are 
not detected along their original LOR. Scattered events are difficult to make corrections for, as the 
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fraction can vary a lot and depend on several factors such as the size of the object being imaged and 
the geometry of the PET-system [29].   
Sensitivity 
The sensitivity of a PET system depends on several physical and technical factors. For simplicity, 
sensitivity can be divided in two major components, intrinsic and geometrical efficiency [28].  
Intrinsic efficiency  
The intrinsic sensitivity depends on the properties of the material the detector is made of. Its 
(effective) atomic number and density determine the linear attenuation coefficient, i.e. its ability to 
attenuate the annihilation photons and ultimately detect its energy. Therefore, the intrinsic 
efficiency is easy to estimate based on the detector material and its thickness. Increasing the 
thickness of the detector allows for a greater attenuation, but comes at the price of greater DOI 
errors (see below).   
Geometrical efficiency 
The geometric efficiency depends on the detector design. A high efficiency is reached if the 
circumferential detector ring is covered with detector area, i.e. if the detectors are packed closely 
enough to not leave any uncovered area. Any intermediate area lacking the ability to detect an 
intrinsic photon, such as spacing in between detector elements, lowers the efficiency.  
The geometrical efficiency can be increased either by reducing the detector ring diameter or by 
increasing the field-of-view. Reduction of the diameter increases the solid angle, but will also reduce 
the spatial resolution by increasing DOI errors (further described below). 
Coincidence Timing Window   
To discriminate against unwanted events, such as scatter and random events, the PET-system uses a 
coincidence timing window. Coincidental events that fall within the timing will be recorded as true 
events. The width of the timing window will determine the level of random events recorded as true 
events, a thin window will reduce the random events contribution to the total of events.  
Spatial Resolution 
Spatial resolution is the measure of how close two lines can be resolved from each other. In PET (and 
many other imaging systems) the spatial resolution is measured as the FWHM of a line spread 
function. The spatial resolution is a function of detector size, positron range and photon acollinearity 
among other factors.  
The National Electrical Manufactures Association (NEMA) guidelines measure the spatial resolution 
with a small point source of 18F in different points of the field of view. The FWHM of the PSF is 
measured in the resulting images. The images should be reconstructed with filtered backprojection 
with rampfilter [31]. 
Depth of Interaction Error 
The Depth of Interaction error (DOI error) arises from the uncertainty of the depth in the detector 
crystal at which the interaction takes place. For LOR:s away from the center field of view, the LOR:s 
and its photons fall in at an angle towards the detector surface normal. Therefore the uncertainty of 
interaction depth leads to a broadening of the events point spread function which is equal to a 
spatial blurring [28]. 
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Preclinical PET 
Small animal PET, or preclinical PET, is increasingly being used for studying cellular and molecular 
processes. In comparison with other molecular modalities, it provides a highly sensitive and 
quantitative measurement of biological processes in vivo [1]. Dynamic processes can be studied in 
real time and be followed over longer periods of time, to see changes in the same animal. Among 
biological and physiological processes PET can be used to study are perfusion, metabolism, protein 
expression and enzyme activity [8]. PET also presents an opportunity in pharmacological studies, 
where it can be used to perform fast in vivo screening of drugs by quantifying their bio-distribution 
[8].  
Most preclinical PET-systems are constructed in similar ways to clinical systems, but on a smaller 
scale. To be efficient for studies of bio-distribution in mice, the resolution must be better than for 
clinical systems, which is in the vicinity of 1 mm. The detector elements are often of a few 
millimeters and due to the much smaller ring diameters, acollinearity is not as much of a problem as 
with clinical PET-systems [8]. Small crystals create an advantage for preclinical PET, since crystal size 
will set the lower limit for the achieved spatial resolution. But, the use of a high number of small 
crystals will demand a high number of electronic channels for the individual signal processing [2]. 
Crystal thickness affects the spatial resolution, especially at the edges of the FOV, due to DOI errors. 
But there are suggested DOI measurements that make use of the interaction depth to improve 
spatial resolution [2].   
The sensitivity of the preclinical system is mainly affected by the solid angle coverage and the 
intrinsic efficiency of the detectors for the annihilation photons energy 511 keV [8]. To improve the 
SNR, acquisition time and injected activity can be increased, but this is limited by the count rate 
capability of the detector. 
The reconstruction methods are basically the same as for clinical PET. Iterative algorithms such as 
Maximum Likelihood Expectation Maximization (MLEM) and Ordered Subset Expectation 
Maximization (OSEM) are used to create a volume representation of the imaged radiotracers 
distribution [2]. In many preclinical systems, filtered back projection is still the dominating analytical 
algorithm. For practical reasons collected data for all projections are collected into sinograms, 
containing every projection of a LOR, that is, every angle collected. Many preclinical PET-systems use 
correction methods known from the clinical systems, such as attenuation correction and scatter 
correction. 
Due to the youth of preclinical PET systems there has been a lack of standardization of their 
properties. Measurements of such as their spatial resolution and sensitivity have been measured in 
different ways.  NEMA NU 4-2008 “Performance Measurements of Small Animal Positron Emission 
Tomographs” defines a model for how to measure and evaluate the properties of systems in a way 
that simplifies comparison between systems [32]. Goertzen et al. used the standard on  a variety of 
preclinical PET systems and concludes that one also must consider the suitability of a system for the 
specific imaging task when considering the results from NEMA testing, since there is a much wider 
variation in system design in preclinical than clinical PET systems [33].   
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Method and Equipment 
Phantoms 
To study how Cerenkov radiation travels through tissue and how its ability to penetrate is limited by 
the tissues absorption and scattering of the light, a phantom should be constructed with precise 
optical properties, which gives a chance to quantify the light output.  
We designed a simple mouse-sized phantom, measuring 9x3x2 cm, drilled through by five thin 
channels at increasing depths. Through the channels a silicon tube was inserted. The tube could be 
filled with a liquid radionuclide, such as 18FDG. The phantom itself was made of epoxy resin, mixed 
with toner ink to make it absorbent of light and TiO2 to make it scatter the light. Epoxy resin has a 
refractive index of 1.54 [10]. With Equation 2 the threshold energy for a positron to emit Cerenkov 
radiation was then calculated to 0,161 MeV.  
 
Figure 5 Phantoms made of epoxy resin. When molded, the epoxy resin was mixed with toner ink to make the phantoms 
absorbent of light by giving them a specific absorption coefficient, and TiO2 to make the resin scatter light by giving the 
phantoms a specific scatter coefficient, given in table below. 
As a first step, eight phantoms were made, with one transparent phantom (A1) made of pure epoxy 
resin without any added absorbent or scatter elements. To enable study of the effects on the 
radiance of absorption and scattering separately, four phantoms had the same absorbing properties 
(C1, C2, C3 and C4) but different scattering properties. Four of the phantoms had the same scattering 
properties (A3, B3, C3 and D3) but different absorbing properties.  
Table 2 The recipe for the eight phantoms. The epoxy resin was made of a two component mix of a base and a catalyst. 
The base was measured and the desired amount of ink stock and TiO2 was mixed with it. To make the resin harden, the 
catalyst was added.  The table states the absorption and scattering coefficient of each phantom.  
Phantom Total mass 
(g) 
Epoxy 
base mass 
Epoxy 
catalyst 
mass 
Toner ink 
mass (g) 
 TiO2 mass µa µs’ 
name (g) (g) (g) (cm-1) (cm-1) 
A1 210 140 70 0.0 0.0 0.00 0.00 
A3 210 140 70 0.0 0.4 0.00 14.74 
B3 210 140 67 3.0 0.4 0.11 14.74 
C1 210 140 64 6.0 0.0 0.23 0.00 
C2 210 140 64 6.0 0.2 0.23 7.37 
C3 210 140 64 6.0 0.4 0.23 14.74 
C4 210 140 64 6.0 0.8 0.23 29.49 
D3 210 140 58 12 0.4 0.46 14.74 
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After the epoxy resin had hardened, the phantoms were cut to the same size and shape and the 
channels were drilled. The shallowest channel was milled into the surface of the epoxy resin 
phantom and light emerging from this channel does not pass through any absorbing or scattering 
material, except for the walls of the silicon tube in which the radionuclide was injected. The tube had 
an inner diameter of 0.8 mm and an outer diameter of 4 mm. The rest of the channels are milled into 
the phantoms at the depths 0.25, 0.5, 0.75 and 1 cm.     
Radioactivity 
For all measurements made at Lund University Bio Imaging Center (LBIC), both CLI and PET studies, 
18F was provided by the Cyklotronenheten at SUS (Skånes univeristetssjukhus). For measurements at 
the Ahmanson Translational Imaging Division at UCLA, 18F was provided by the UCLA Ahmanson 
Biomedical Cyclotron Facility.  
The CLI-system at Lund University Bioimaging Center 
At Lund University Bioimaging Center (LBIC) a novel laboratory-built CLI system is used for 
fundamental studies of Cerenkov emission from injected mice. It consists of a light-tight box with a 
CCD-camera mounted on top, looking down towards the floor of the box. The CCD has a wide angle 
lens, mounted inside the box, to collect light from a wider angle across the bottom of the box. The 
CCD is connected to a cooling system, lowering the electric noise in the signal. The CCD-camera is 
directly connected via USB to a computer, making data collection immediate and assessment quick.  
  
The CCD has previously been calibrated with a light source of a known radiance, which makes it 
possible to directly calculate the radiance from the pixel values of the images. The calibration gives a 
calibration factor which is included in the MATLAB program OptiScope (described below). During 
imaging, lights in the laboratory are turned off to minimize ambient light increasing the background 
level.   
Figure 6 Left image: the CLI-box open with dark drapes pulled back. The object meant for imaging is placed at the 
bottom of the box directly underneath the CCD on the top of the box facing the bottom.  A white light image of the 
object is taken this way and is later used to overlap the CLI images for an anatomical reference. Right image: The CLI-
box closed and with the drapes pulled down to shut out ambient light. The CCD is connected to a laptop containing the 
software controlling its settings. When imaging, the overhead lights in the laboratory are switched of.  
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Specifications CLI system 
Table 3 Specifications of components for laboratory-built CLI-system. 
Attribute Modell 
CCD model Andor iKon-M DU934P-FI 
CCD-chip e2V CCD47-10, 1024x1025 pixels, 13 µm pixels 
size, 13.3 mm sensor size 
Lens  Schneider Kreuznach Xenon f/#0.95, F 25 mm, C-
mount 
Software Andor SDK 2.92, Andor SOLIS 4.20 
 
CLI measurements  
The phantoms were filled with 18F at the start of each experiment. The activity injected in each 
phantom came from the same batch, why all phantom tubes contained activity of the same 
concentration, even if the full tube didn’t hold the exact same amount of activity. The measured 
radiance from a channel would be fitted against the activity in that channel, and as the channels 
were made to be of the same size, they were assumed to contain the same volume and therefore the 
same activity. Normally, four phantoms were filled for the same experiment and imaged two and 
two, by alternating the phantoms placed in the CLI system.  
For the phantom studies in this project, the radiotracer-filled phantoms were placed, two at a time, 
at the bottom of the CLI-system. Images were collected with the CCD. This was set to collect 16 bit 
gray images for the full data range (0 – 65535).  The pixels were binned 4x4, which means the images 
became 256x256 pixels. The images were collected for a variation of exposure times, 10-600 seconds 
to enable evaluation of an appropriate exposure time as a function of the activity. Specifically at the 
beginning of an experiment, while the activity concentration was high, shorter exposure times were 
used, as the noise level became too high, due to annihilation photons, in images taken with the 
longer exposure times. As time passed, longer exposure times became necessary to detect the 
decreasing radiance. 
To avoid light scattering and increasing the signal in neighboring channels, the silicone tube was 
pulled through every second channel, increasing the distance between radioactivity-filled channels. 
This meant every phantom must be imaged at two different occasions to give data for all channels. 
Neighboring empty channel would in some cases light up as if filled will radioactivity due to 
reflections, but at a lower intensity. The intensity profiles over the different channels filled with 
activity were now separated enough to not overlap. 
Images were then collected for the duration of a couple of half-lives of the radiotracer. At the 
beginning of an imaging session an image was taken as a localization reference. The image was taken 
while the door to the CLI-system was open. This image was later superimposed on the CLI-image, 
which made it easier to tell the localization of the light source. 
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Figure 7 Phantoms A3 and B3 filled with 
18
FDG and imaged CLI system at LBIC. Left image: Phantom A3 and B3 imaged 
with three channels filled with activity. In A3 the empty channels light up as if filled with radioactivity (but as if of a lower 
activity concentration), due to scattered light reflecting in the channel walls. Right image: phantoms A3 and B3 filled with 
18
F in the remaining channels not filled in the left image. 
 
Data processing – MATLAB 
The images taken with the CLI-system were read and processed with the help of a custom-made 
MATLAB-program (OptiScope, Johan Axelsson). The program superimposes the CLI-image with the 
white light imaging. The pixel values of the CLI-images were converted to radiance with the 
previously known calibration factor. With the program the images can be windowed to visualize the 
emission from the channels in the phantoms.  
To retrieve the radiance from each channel of the phantom, the phantom in the image was marked 
with a region of interest (ROI). Profiles along the long side of the phantoms were drawn and an 
average of these was calculated. For each average profile ten lines of pixels were combined. An 
average profile along the middle of the phantom was chosen.  
The maximum radiance from the profile over a channel was picked as measurement of the radiance 
of that channel. To evaluate the resolution of the CLI-system, the profile over each channel was fitted 
to a Gaussian function with the help of the MATLAB application Curve Fitting Tool3. The application 
gives the function on the form 
 ( )     
 (   ) 
    
Equation 19 
The full width at half maximum (FWHM) can then be calculated from the term c as 
        √   ( )            
Equation 20 
With the knowledge of the pixel width in the image, the FWHM could then be calculated.  
                                                          
3
 Curve Fitting Toolbox 3.3, Copyright 2001-2012 The MathWorks, Inc. 
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NanoPET/CT at LBIC  
The NanoPET/CT (BioScan) is available at LBIC, and used for small animal imaging of mice and rats. It 
comprises of 12 detector arrays of LYSO scintillation crystals. It is stated to have a spatial resolution 
of less than 1.2 mm in the center field-of-view (CFOV) and a sensitivity of 8.3 % at CFOV for an energy 
window between 250-750 keV [34]. The system has a field-of-view (FOV) of 100x94 mm. 
 
Figure 8 The NanoPET/CT at LBIC. 
Reconstruction is done with an iterative 2D OSEM algorithm.  
Siemens Inveon  
At the Ahmanson Translational Imaging Division at UCLA, the Inveon microPET (Siemens) system is 
used for small animal imaging. The system uses LSO scintillation crystal detectors and has according 
to the manufacturer a resolution (FWHM)  in the CFOV of 1.4 mm [35].  
 
Figure 9 Left image: The Inveon PET-system (Siemens) at the Ahmanson Translational Imaging Division at UCLA.  
Right image: the PET-systems mouse cradle in which the phantoms where mounted during the scan. 
The sensitivity is greater or equal to 10 % at the CFOV [35]. 
The reconstruction is made with an iterative OSEM algorithm.  
Genisys4 Table Top PET 
The Genisys4 (Sofie Biosciences) differs from most preclinical PET system in that it consist of four 
detector panels, instead of multiple detectors as in detector ring PET scanners. This gives it different 
properties, even though the basic idea of detecting true coincidences is still there.  
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A first basic description of the system and its performance was given by Gu et al [36]. They described 
the precursor to the Genisys4, the PETBox4, as consisting of four opposing detector panels arranged 
in a box like geometry. Each panel is made by a 24 x 50 array of 1.8 x 1.8 x 7 mm BGO scintillation 
crystals. Each panel is coupled to two PM-tubes via a glass light guide. The FOV is 4.5 cm in a 
transaxial direction and 9.4 cm in the axial direction. The system uses a MLEM algorithm to 
reconstruct images. The system has an X-ray system for reference images and attenuation 
corrections.  
To evaluate the system performance, Gu et al. measured the sensitivity with a drop of 18F placed in 
the CFOV [36]. With an energy window between 150 - 650 keV and a timing window of 20 ns the 
peak sensitivity was found to be 14%, which is quite high compared to conventional preclinical PET 
scanners. The spatial resolution was measured with a 22Na point source. The intrinsic spatial 
resolution was found to be 1.5 mm in both axial and transaxial directions. The reconstructed spatial 
resolution was on average 1.46 mm.  
The performance of Genisys4 has been evaluated and compared to other preclinical PET scanners by 
Bai et al[37]. The comparison was made with the first generation of commercial scanner microPET R4 
and its latest generation scanner Inveon (Siemens). It should be noted that scatter correction wasn’t 
available for Genysis4 but for the two conventional scanners. Bai et al. came to the conclusion that 
Genisys4 had a resolution comparable to the other scanners, but that its images had an increased 
background activity [37]. A reason for this might be the quite wide energy window, which will allow a 
lot of scatter events to be detected as coincidences. This could be minimized with scatter correction. 
Bai et al also noted that Genisys4 could provide high quality images with activities as low as 37 kBq.   
The system was further evaluated by Hermann et al [38]. They compared the system’s ability to 
detect subcutaneous xenographs and lung metastases with that of an established preclinical PET. 
They found the Genisys4 to detect these equally well as the established system.  
At the Ahmanson Translational Imaging Division at UCLA the Genisy4 is used for small animal 
imaging.  
 
Figure 10 Left image: The Genisys4 PET-system (Sofie BioSciences) at the Ahmanson Translational Imaging Division at 
UCLA. Right image: the PET-systems mouse cradle in which the phantoms where mounted during the scan. 
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Data collection for the PET-systems 
For all three PET-systems (Siemens, BioScan and Sofie Biosciences), dynamic measurements were 
made, imaging one of the phantoms filled with 18F in all the channels. For the Genisys4 and the 
Inveon, measurements were made by five minutes dynamic data collection for a number of hours. 
Several images where analyzed and the best results are presented below. For the measurement with 
the NanoPET/CT at LBIC a 20 min dynamic study was made.   
To evaluate the spatial resolution of the measurements, the same technique as that used to evaluate 
the FWHM for the CLI images was used. Profiles over the channels where fitted to a Gaussian curve 
with the MATLAB application Curve Fitting Tool4. The term c (from Equation 19) given by the fitting 
tool was used to calculate the FWHM from Equation 20. 
The sensitivity was evaluated by comparing the number of prompt coincidences measured during the 
dynamic scan to the calculated number of decays from the known activity in the phantom. The quota 
gives the sensitivity in %.   
                                                          
4
 Curve Fitting Toolbox 3.3, Copyright 2001-2012 The MathWorks, Inc. 
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Results - CLI 
The radiance from each channel of the different phantoms was analyzed with the MATLAB program 
OptiScope (described above) for a large number of images collected over a couple of hours during 
which the 18F decayed. As the activity decays, it gives an opportunity to measure the radiance from 
decreasing activities in the channels.  
Radiance vs. activity of 18F  
In Figure 11 a representative plot of the radiance from the five channels in phantom A3 is plotted as 
a function of the activity concentration of 18F in the channels. All phantoms show the same trend and 
all give support to the same theoretical expectations.   
 
Figure 11 The radiance from all channels in phantom A3 plotted as a function of the activity of 
18
F in the channels. The 
radiance deceases with a decreasing activity. The radiance is consistently lower for deeper lying channels. 
The trend of an increasing linear relationship between activity and radiance is consistent throughout 
all channels in all phantoms. This is an expected result related to the theory and the description of 
the origin of Cerenkov radiation.  
In the Frank Tamm formula in Equation 4 and Equation 5, the energy of the Cerenkov radiation 
emitted by a charged particle is described. These equations states that the light is emitted as a 
continuous spectrum. All charged particles with sufficient energy will emit light with the same 
spectral distribution; higher energies will raise the intensity. In a similar way the energy distribution 
for emitted positrons from 18F does not change when the activity is increased, it will only increase the 
intensity. As the activity increases so does the flux of positrons with sufficient energy to emit 
Cerenkov radiation. More positrons emitting Cerenkov radiation will lead to an increase in the total 
amount of light emitted and a larger radiance detected.  
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These plots also show a decreasing radiance with increasing depth. Cerenkov radiation produced 
deeper inside the phantom must travel a longer distance and will then be more affected by the 
absorbing and scattering properties of the phantom. This is consistent with the theoretical 
description of the radiance decreasing as a function of the distance R traveled through a material of 
the effective attenuation coefficient      as described in Equation 14. 
Radiance vs. absorption coefficient  
The radiance of the four phantoms with the same scattering properties but varying absorption 
coefficients (A3, B3, C3 and D3, see Table 2) is plotted as a function of the activity of 18F in each 
channel. One plot is made for each depth of the channels.  A linear function is fitted to each data 
series.  
For the depths 0.25-1 cm a clear decrease in the slope of the linear relationship between radiance 
and activity is seen for an increasing absorption coefficient. This is shown for the depth 0.25 cm in 
Figure 12 below. The depths 0.5-1 cm are not shown but display the same relationship between 
absorption coefficient and the slope of the linear function. 
 
Figure 12 The radiance measured form the channels at the depth 0.25 cm plotted aginst the avtivity of 
18
F in the channes. 
The radiance deceases from phantoms with a higher absorption coefficient.  
For the depth 0 cm the radiance is expected to be decreased with decreasing activity of 18F, according 
to the same linear relationship for all phantoms. This channel is at the surface of the phantom and 
the emitted Cerenkov radiation should all be from the silicon tube. But due to scattering in the 
channel walls and variations in the exact position of the drilling of the channel, the radiance varies in 
an inconsistent way between the four phantoms, as can be seen in Figure 13 below.  
37  
 
 
Figure 13 The radiance from the four phantoms with varying absorption coefficient at the most shallow channel.  
The fitted linear functions for the four different values of absorption coefficient are used to calculate 
the radiance as a function of absorption coefficient for a variety of 18F activities. Below in Figure 14 
the radiance is plotted for an activity of 3 MBq 18F in the channels.  
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Figure 14 The radiance of Cerenkov radiance has a decreasing relationship to an increasing absorption coefficient.  
In Figure 14 a clear decreasing relationship between radiance and increasing absorption coefficient is 
apparent. This is, as described for Figure 12, an expected result from the theory, in accordance with 
Equation 14.   
Radiance vs. scatter coefficient 
The four phantoms with varying scatter coefficient (C1, C2, C3 and C4, see Table 2) are plotted for 
each depth of the channels. Below in Figure 15 the radiance for the channel at the depth 0.50 cm is 
shown, and a linear function is fitted to the data from each phantom.  
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Figure 15 The radiance as a function of activity of 
18
F in the channels at the depth 0.50 cm in the four phantoms with 
varying scattering coefficient. With exception for phantom C1 without any added scattering Ti02 and therefore a 
theoretical scattering coefficient of 0 cm
-1
, the slope of the fitted linear functions increases as the scattering coefficient 
increases.    
The plotted data in Figure 15 shows the same trend for all depths (0.25 - 1.00 cm) of the four 
phantoms. Excluding phantom C1, the plots show an increasing inclination to the fitted functions for 
an increasing scattering coefficient. With a higher scattering coefficient, the light traveling through a 
material can propagate longer distances due to a greater number of scattering events. As the 
scattering coefficient is increased, more light is scattered up to the surface.  
But, enough scattering can also dampen the light radiance as it is scattered into a bigger volume of 
the phantom. And during the longer distance travelled by the light, a larger number of absorptions 
will occur. This can explain why phantom C1 displays a level of radiance comparable to phantom C4. 
When going from no scattering to the lowest level examined in this study, the light is reduced in the 
forward direction due to scatter. As the scattering level is increased more light emitted in the 
opposite direction from the surface can be scattered all the way to the surface and we get an 
increasing radiance. If phantoms with even higher scattering coefficients had been made, a possible 
observation could have been a point at which the radiance starts to decrease due to “too much” 
scatter.  
Linear functions are fitted to the data series in Figure 15 and used to calculate and plot the radiance 
as a function of the scattering coefficient. This is done for an activity of 3 MBq in the channels and 
plotted for the different depths of the channels in Figure 16. 
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Figure 16 The radiance from the channels of different depths in the phantoms plotted as function of the scatter 
coefficient. With the exception of the data points for a scatter coefficient of 0 cm
-1
 an increasing trend for increasing 
scatter coefficient. 
If excluding the data points from the lowest scattering coefficient (0 cm-1 in phantom C1), a trend of 
increasing radiance with increasing scattering coefficient can be observed. It seems as if the highest 
scattering coefficient plotted has its biggest impact on the deeper situated channels, as these 
become more separated in the plot.   
FWHM vs. depth 
The phantom A1 has no additives to give it any scattering or absorbing properties. Therefore it is 
used to study the effects of depth independent of scattering and absorption. The measured FWHM 
as a function of depth is plotted in Figure 17 below. 
41  
 
 
Figure 17 The influence of depth on FWHM independent of scattering and absorption.  
An increasing trend is observed between FWHM and depth. 
FWHM vs. absorption coefficient 
The FWHM is analyzed from the data of the phantoms with varying absorption coefficient (A3, B3, C3 
and D3, see Table 2) for different depths of the channels.  Linear functions are fitted to the data. The 
linear functions found through the regression are then used to calculate the FWHM for a variety of 
depths. The result is given in Figure 18 below.  
A trend of decreasing FWHM with increasing absorption coefficient is seen in Figure 18 below. This is 
explained from the fact that a higher absorption coefficient will attenuate photons that travel long 
path lengths through the tissue. This renders a more narrow intensity distribution at the surface, i.e. 
a smaller FWHM. 
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Figure 18 The FWHM plotted as a function of the absorption coefficient for a variation of depths. A decreasing radiance 
with an increasing absorption coefficient is observed.  
FWHM vs. scattering coefficient 
For the four phantoms with varying scattering coefficient (C1, C2, C3 and C4, see Table 2), the FWHM 
is analyzed as a function of the depth of the channels (not shown). Linear functions are fitted to the 
data points. These are used to calculate the FWHM for different depths and are plotted below in 
Figure 19. 
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Figure 19 The FWHM at the surface of the phantoms as a function of the scatter coefficient plotted for a variation of 
depths.  An increasing FWMH with an increasing scatter coefficient is observed.  
A vague trend of an increasing FWHM with increasing scattering coefficient can be observed. This is 
consistent with the theoretical expectations, a highly scattering material will broaden the profile of 
the light emitted as it is scattered over a wider angle, and therefore giving a broader FWHM. 
In both Figure 18 and Figure 19 we see an increasing FWHM as the depth of the source is increased. 
As the light travels longer distances, more scattering events occur and the profile therefore 
broadens.  
The data points from µs’ = 0 cm
-1 differs from the trend of the other. These originate from the linear 
fit from the FWHM data from phantom C1.  Since the tubes outer diameter is 4 mm, we expect a 
FWHM in the vicinity of this value if there is no scattering.  The points therefore seem to be in 
consistence with the expected result. 
Results - PET  
From the three measurements made on the three different PET-systems (Genisys4 (Sofie 
BioSciences), Inveon (Siemens) and NanoPET/CT (BioScan)) the FWHM and the sensitivity has been 
calculated as described above. The results are presented in Table 4 and Table 5 below. 
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FWHM 
Table 4 The measured FWHM from the dynamic measurements made on the PET-systems Genisys4 (Sofie BioSciences), 
Inveon (Siemens) and NanoPET/CT (BioScan). The smallest FWHM and therefore best spatial resolution is given by the 
NanoPET/CT (BioScan). 
PET-system FWHM (cm) FWHM  (CFOV) according to 
manufacturer (cm) 
Genisys4 0.24 0.14 
Inveon 0.20 0.14 
NanoPET/CT  0.18 0.12 
 
Sensitivity 
Table 5 The measured sensitivity from the dynamic measurements made on the PET-systems Genisys4 (Sofie 
BioSciences), Inveon (Siemens) and NanoPET/CT (BioScan). The highest sensitivity is given by the Genisys4 system (Sofie 
BioSciences). 
PET-system Measured sensitivity (%) Sensitivity according to 
manufacturer (%) 
Genisys4 5.9 14 
Siemens Inveon 1.4 10 (CFOV) 
NanoPET at LBIC 3.5 8.3 (CFOV) 
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Discussion  
CLI 
Throughout this thesis, the results have shown a basic consistency with the fundamental theory of 
the origin of Cerenkov radiation and the attenuation of optical light in tissue. It is evident that 
Cerenkov radiation is affected by both absorption and scattering in different ways. Employing the 
phantom set, developed within this work, it is possible to investigate the impact of depth, absorption 
and scattering separately.  
Cerenkov radiance vs. activity 
Figure 11 showed an increasing radiance as a function of activity in the channels. This is  logical 
consequence, since a higher activity of 18F causes a higher radiance. The higher activity gives rise to a 
higher flux of positrons in the channels and the phantom, emitting the Cerenkov light. This is 
consistent with the results presented previously by many, including the initial study on CLI by 
Robertson et al [12].    
During the CLI measurements, it was noted that high activity and long exposure times resulted in 
very noisy images. For phantoms of a high effective absorption coefficient this noise was enough to 
drown the signal from the deeper channels. The noise is assumed to be due to high energy photons, 
such as the annihilation photons or secondary Compton scattered photons, hitting the CCD and 
“killing” pixels by saturating them. A shorter exposure time will limit the noise, since fewer pixels will 
be saturated before the shutter is closed. Intuitively, a lower activity will give a lower noise level, 
since the flux of annihilation photons and its progeny from interactions are directly proportional to it.      
During imaging, it was noted that empty channels in the phantoms lit up due to reflections, as 
showed in Figure 7. The radiance from these channels was ignored and never measured. But it still 
raises the question whether similar reflections in tissue could create false sources of light. It could 
potentially happen in cavities such as lungs, but would probably not be a problem in denser tissues.  
Influence of depth (radiance and resolution) 
Figure 11 also showed the impact of depth in the phantom, indicating the effective attenuation of 
light as it passes through the phantom. The radiance detected at the surface is therefore dependent 
on the distance the light has travelled as described by Equation 14. This shows consistency with the 
previously mentioned work by Park et al, showing the smallest activity concentration of 124I 
detectable with CLI after injection in the back muscle of rats increased for growing depths [20].  
In Figure 18 and Figure 19 the influence of depth on the resolution becomes evident. As the depth is 
increased the FWHM is broadened. The FWHM, depending on depth and phantom, varied between 
0.4 - 3.8 cm, a very large span. The biggest variation of FWHM calculated for the depths 0.1 - 1.0 cm 
within the same phantom was found for phantom A3 which showed a FWHM span of 0.6 - 3.2 cm. In 
the previously mentioned study by Liu et al, a spatial resolution of 1.2 mm for CLI using 18F was 
measured [14]. This is obviously a large difference to the results of this thesis, but it is clearly due to 
the different methods used. Liu et al used a Micro Deluxe phantom, normally used for spatial 
resolution assessments for established nuclear imaging modalities, and not a line source like the 
channels in this study’s phantoms. There measurement did not take depth, absorption and scattering 
into account for the potential spatial resolution of CLI [14].   
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When light travels longer distances through a scattering medium it will be subjected to more 
scattering events, all widening the distribution of the light. All phantoms (except C1 and A1, A1 is not 
contributing with any data in these results) have a scattering component. This includes the four 
phantoms with varying absorption coefficients (A3, B3, C3 and D3).  
Phantom A1, as can be seen from Table 2, has no additives to give it any scattering or absorbing 
properties. The FWHM measured for the depths of the channels is plotted in Figure 17. A small 
broadening of the FWHM is seen for greater depths. This implies that the FWHM is a function of 
depth independent of the scattering and absorbing properties of the medium. This is in consistency 
with the inverse square law, since the sphere area A of the light distribution has a      
relationship to the radius r. The radius is here the distance from the channel to the surface. As the 
area of the sphere is increased, the angle at which the light hits the surface is also increased. From 
the law of refraction it is evident that if the incident angle of a ray is increased, so is the angle of the 
refracted ray. This leads to a broadening of the FWHM. 
The depth of an activity uptake will inevitably limit the chances to detect and quantify it. It will 
appear broader, due to the larger FWHM, and less radiant, due to the divergence and absorption of 
the light.  
Influence of absorption (radiance and resolution) 
The impact of the absorption coefficient on radiance is investigated in Figure 12 to Figure 14. A 100 % 
increase of absorption coefficient from 0.11 cm-1 to 0.23 cm-1 reduced the radiance by 60 % from the 
channel at depth 0.5 cm when filled with 3 MBq 18F. The decreasing radiance for an increasing 
absorption coefficient is due to greater light absorption which can be theoretically described by the 
effective attenuation coefficient in Equation 13. 
The relationship studied is according to the theory in Equation 14 an exponentially decreasing 
relationship. Exponential functions could be fitted to the data in Figure 14 with accuracy R2 between 
0.85-0.88 for the four different data groups. A better fit could possibly been made if the radiance had 
been plotted against the effective attenuation coefficient rather than the absorption coefficient. If 
scattering could be considered negligible the radiance could be described by the Beer-Lambert law, 
Equation 11, but since the phantoms used for evaluating the absorption all have a scattering 
component, Beer-Lambert law is not valid.  
In Figure 18 the FWHM showed a decreasing trend for an increasing absorption coefficient. When 
the intensity profile of the light propagates through the medium it will attenuate it in accordance 
with the absorption coefficient of the medium. The fading, less intense radiance at the wings of the 
profiles will be absorbed. The profile will therefore become narrower for each unit length it travels 
through the medium.    
Absorption will more than the other factors limit the sensitivity of a CLI-system.  
Influence of scattering (radiance and resolution) 
Figure 16  shows an increasing radiance as an effect of an increasing scattering coefficient. A 100 % 
increase of scattering coefficient from 7.37 cm-1 to 14.74 cm-1 increased the radiance with 54 % from 
the channel at depth 0.5 cm when filled with 3 MBq 18F. This is a slightly more complex relationship 
than that seen for the absorption coefficient, since the effect of scattering could both be expected to 
raise the measured radiance and lower it.  The scattering properties of the material can scatter light 
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not travelling towards the surface to change its direction sufficiently to reach the surface. But, it will 
also have a reducing affect as the scattered light travels a longer distance and therefore is more 
absorbed along the way to the surface.  
As mentioned in the results for Figure 15, the radiance measured for phantom C1 is not actually 
subjected to any scatter since it has no added TiO2 giving it scattering properties. The radiance 
measured is attenuated due to the absorption coefficient of the phantom and the distance travelled 
through it.  The scattering of the remaining phantoms probably lowers the intensity due to the longer 
distance travelled through an absorbing medium, compared to the distance travelled by the light 
photons in phantom C1. As the scattering coefficient is increased, more light is scattered towards the 
surface and the radiance from the most scattering phantom (C4) reaches a level comparable to that 
of C1. It is plausible that the attenuating effects due to the longer distance travelled could have more 
impact for even higher scattering coefficients. If phantoms with even higher scattering coefficients 
had been made, we might have observed a point at which the radiance falls due to increasing 
scattering. Unfortunately no time was found within the scope of this project to construct more 
phantoms. The phantoms constructed were designed to cover the commonly found absorbing and 
scattering coefficients found in biological tissue.    
In Figure 19 the FWHM showed a trend of broadening as the scattering coefficient increased. This is 
consistent with theoretical expectations. When light is scattered its intensity profile is broadened. 
Similar to previous plots, the data points for µs’ = 0 cm
-1 did not really follow the trend of the other 
points. These data points come from the measurements of the FWHM from phantom C1, which as 
described in the previous paragraph has not been subjected to any scattering. The absorption 
coefficient of the phantom is expected to narrow the profiles of the light and this is the same for all 
four phantoms.  
CLI for quantitative longitudinal studies 
Since CLI is influenced by optical properties it can’t be directly used for quantitative studies. For this 
to become possible some form of attenuation correction would be needed. Such a correction is 
achieved in conjunction with CLT, using additional light sources, but will undoubtedly lead to longer 
examination times. Another approach would be to assess the effective attenuation coefficient 
separately using an external light source.  
The main motivation for developing such attenuation correction scheme is that the optical properties 
can very likely change during the course of treatment. Most importantly the absorption properties 
due to blood, since changes in vascularity and oxygen saturation are probable responses to radiation 
therapy. It has been shown that vascularity, blood volume and blood flow can change significantly as 
a response to radiation therapy [39, 40]. An increasing blood flow and blood volume would increase 
the effective attenuation coefficient. If this happens fast and at a sufficient rate, i.e. during the 
duration of a mouse participation in a study, it will perturb the measured radiance.  
The two studies quoted above are from human and canine subjects. It is likely that the response to 
radiation therapy is strongly dependent on tumor type. Similar studies have been made for mice.  
Fujii et al. studied the oxygen partial pressure for a squamous cell carcinoma bearing animal model 
following external beam radiation therapy. It was seen that the oxygen content in the tumor 
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increased rapidly and then decreased slowly to pre-irradiation levels within less than two weeks. A 
lower absorbed dose rendered a faster return to pre-irradiation oxygenation [41]. 
Vishwanath et al. studied the oxygen saturation following external radiation therapy of a murine 
animal model inoculated with head and neck cancer cells. The results indicated a gradual increase in 
oxygen saturation from 5 to 17 days post irradiation. However, they did not see any changes in the 
blood volume. This finding is important since a constant blood volume will keep the average 
absorption coefficient the same whereas the change in oxygen saturation will only change the 
absorption spectrum of hemoglobin, rendering only small changes in the effective attenuation 
coefficient across the visible spectrum [42].  
These two studies indicate, by proving changes in oxygen content in tumors and oxygen saturation of 
blood but not blood volume, that there are changes in optical properties during radiation therapy. 
However, the changes are mostly due to oxygenation changes and the total optical absorption seems 
to be more or less constant.  
To visualize the difference in impact on the absorption between oxygenation and change in blood 
volume, the absorption coefficient can be calculated from Equation 12. This is done by using the 
extinction coefficients of oxy- and deoxygenated blood. The result is plotted in Figure 20.  
  
Figure 20 Left image: the absorption coefficient as a function of wavelength for four levels of oxygen saturation. Right 
image: the absorption coefficient as a function of wavelength for three levels of blood volume.  
The influence of these small changes in absorption spectrum is moderate when studying superficially 
emitted Cerenkov radiance, as indicated by the results in this thesis, as well as previously reported 
publications that has shown good correlation between CLI and PET measurements of shallow activity 
uptakes in vivo [15, 18, 21]. However, a deeper lying Cerenkov emitter will be more affected, 
rendering a need for attenuation correction of the emitted light. 
On the other hand, due to the influence of optical properties, there are possible means of using the 
Cherenkov emission for analysis of the tissue or tumor physiology. Changes in emitted Cerenkov 
radiation could potentially indicate oxygenation of hypoxic tumor cells, or shrinkage of the whole 
tumor volume from changes in light propagation depth. 
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Positron Emission Tomography 
FWHM 
The results in Table 4 show a slightly broader FWHM for all PET-systems compared to the FWHM 
reported by the manufacturers. These measurements are not optimized for FWHM evaluation. 
FWHM measurements are, according to the NEMA NU-2008 standard, preferably made with a 22Na 
point source [32]. Instead we used several line sources within a phantom filled with 18F. Our 
phantoms were constructed with the CLI measurements in mind, and did not intend to make spatial 
resolution measurements to fully evaluate the PET systems, but to give a comparison to the CLI 
measurements of the same geometry.  
The best resolution of the systems is given by the NanoPET/CT system, which has the best stated 
resolution out of the three systems, according to the manufacturers.  
Sensitivity 
The results in Table 5 show a rather large difference between the sensitivities measured and the 
ones stated by the manufacturers for all the systems tested in this thesis. But, it points to a similar 
relationship of capacity between the different systems, with the Genisys4 giving the best sensitivity.  
But again, the method used is not the NEMA NU-2008 standard [32]. Sensitivity should according to 
the standard be measured with a 22Na point source placed at the CFOV. In this case the activity is not 
a point source but spread out over most of the FOV. Also, the standard states that the reconstruction 
should be made with a filtered back projection. These systems used different versions of iterative 
reconstruction algorithms. 
PET vs. CLI 
These preclinical PET measurements were not made to show the sensitivity and spatial resolution at 
optimal conditions, but to offer a comparison for the CLI measurement. Since the sensitivity and 
FWHM depends on different factors for PET and CLI, the phantoms were made with the CLI-
measurements in mind and did not consider the PET measurement more than to make sure the 
phantoms would fit in the different PET-systems.  
The sensitivity in PET gives a correlation to its ability to quantify activity uptake. Since the number of 
expected coincidences is directly a function of activity, quantifications can easily be done with a high 
accuracy in PET. For CLI the radiance does not have the same direct relationship to activity and we 
cannot really calculate the sensitivity as a property for CLI.  It would, as discussed above, take some 
form of normalization for the optical properties.  
The spatial resolution is also dependent on different factors for CLI and PET, but can still be 
measured in a suitable way for CLI. A big difference between the two modalities is the depth 
dependence for the FWHM in CLI. The high energy annihilation photons are slightly attenuated 
through the phantoms but most systems apply scatter and attenuation corrections. It also won’t 
make a big difference between oxy- and deoxygenated blood, but will be equally attenuated by both.  
We therefore see a big variation of FWHM for CLI from down to 4 mm up to a few centimeters for 
deeply situated channels in highly scattering phantoms.  The PET systems on the other hand can be 
trusted to resolve structures down to a few millimeters.  
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The CLI-system will never challenge preclinical PET as a quantitative modality, but do pose an 
opportunity for imaging schemes taking advantage of both modalities’ benefits. Quantitative PET and 
effective attenuation coefficient assessment at the starting point of a longitudinal study could enable 
tumor model assessments with CLI, with PET providing tumor uptake validation and effective 
attenuation coefficient assessment offering a way to normalize the Cerenkov radiance for activity 
uptake.  Using a combined imaging approach would decrease the machine time for PET imaging since 
the number of PET scans is reduced. Here CLI could find a place for serial imaging of radionuclide 
uptake in subcutaneous tumors. The method of this thesis could potentially form the foundation for 
a standard quality assessment method for CLI. Like preclinical PET has the NEMA NU-2008 standard 
giving directions for quality assessment, CLI if used for preclinical studies, would need standards for 
evaluation of the imaging technique quality to make studies comparable. The method could include 
schemes for evaluating the imaging properties of new radionuclide compounds in a standardized 
way, potentially with phantom studies similar to those performed in this thesis. 
Conclusion 
This thesis has investigated the potential of CLI as a new preclinical imaging modality. The results 
pointed out the need for effective attenuation coefficient assessment as an initial step in longitudinal 
studies and the limits of what depths could be correctly imaged. CLI lack the ability to perform 
quantitative uptake measurements, but benefits from quick image acquisition with a direct readout 
of radiance without need for tedious image reconstruction. In combination with quantitative PET, CLI 
could be part of a longitudinal imaging scheme where serial CLI measurements reduce the need for 
repeated PET imaging.  
The method of this thesis could also form the foundation for a standard quality assessment method 
for CLI. Like all imaging modalities, CLI needs a standard for evaluation of the imaging technique 
quality. The method could include schemes for evaluating the imaging properties of new radionuclide 
compounds in a standardized way with phantom studies similar to those performed in this thesis. 
CLI will not take the place of already available preclinical imaging modalities such as PET and SPECT, 
as it is unable to perform quantitative uptake measurements on its own. But it can become a 
compliment in future longitudinal imaging schemes, lowering the machine time needed for PET or 
SPECT and adding a faster and less complicated technique for serial imaging.  
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